<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02589860</url>
  </required_header>
  <id_info>
    <org_study_id>IUSCC-0536</org_study_id>
    <nct_id>NCT02589860</nct_id>
  </id_info>
  <brief_title>Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant</brief_title>
  <official_title>A Pilot Study: Gene Expression and Bacterial Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sherif S. Farag</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to explore and identify changes in molecular processes within the oral&#xD;
      mucosa that are associated with the development of oral mucositis (OM) in patients treated&#xD;
      with Melphalan who undergo autologous peripheral blood stem cell transplantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an exploratory observational (non-therapeutic) study to collect blood and buccal&#xD;
      mucosal samples to evaluate RNA expression, assess bacterial colonization, and plasma&#xD;
      Melphalan concentrations in approximately 50 eligible patients.&#xD;
&#xD;
      All study samples will be collected from participants while they are hospitalized to receive&#xD;
      standard of care high-dose Melphalan (HDM) chemotherapy and autologous peripheral blood stem&#xD;
      cell transplantation (ASCT). Patients who receive this treatment are typically admitted the&#xD;
      day before HDM. The day after HDM, patients receive ASCT and remain hospitalized for&#xD;
      approximately 21 days, or until their absolute neutrophil count increases to at least 500&#xD;
      cells per mm3 and they are no longer considered neutropenic.&#xD;
&#xD;
      Patients will have blood samples collected for pharmacokinetic analysis at approximately 0&#xD;
      minutes (before infusion begins), 15 minutes (during the infusion), 30 minutes (at the end of&#xD;
      infusion), 60 minutes, 90 minutes, 120 minutes, and 180 minutes after the start of Melphalan&#xD;
      infusion.&#xD;
&#xD;
      A buccal swab will be done to collect mucosal bacterial samples using paper strips&#xD;
      (Periopaper) or a sterile cotton tipped swab brushed against the right and left buccal mucosa&#xD;
      for approximately 15-30 seconds at the following time points:&#xD;
&#xD;
        1. Within 24 hours PRIOR to administration of Melphalan&#xD;
&#xD;
        2. Day +3 AFTER transplantation&#xD;
&#xD;
        3. Upon development of OM (approximately on days +7-10)&#xD;
&#xD;
        4. Upon recovery of absolute neutrophil count (ANC) to greater than 500/mm3, or on&#xD;
           discharge, whichever occurs first, in patients who developed OM&#xD;
&#xD;
      A buccal scraping will be done for gene expression using a dermatologic curette taken from&#xD;
      the right and left buccal mucosa at the following time points:&#xD;
&#xD;
        1. Within 24 hours PRIOR to administration of Melphalan&#xD;
&#xD;
        2. Day +3 AFTER transplantation Note: Patients' mouths will be rinsed with Mary's Magic&#xD;
           mouthwash prior to the procedure for 15 seconds, which will allow for removal of food&#xD;
           particles, colonized bacteria and anesthetization of oral mucosa. During procedure, any&#xD;
           signs of patient discomfort will be monitored. If patient expresses discomfort,&#xD;
           additional oral topical anesthetic will be utilized to de-sensitive buccal mucosa.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No accrual&#xD;
  </why_stopped>
  <start_date type="Actual">October 30, 2015</start_date>
  <completion_date type="Actual">March 23, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gene expression</measure>
    <time_frame>30 days</time_frame>
    <description>RNA sequencing from oral buccal mucosal cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bacterial colonization</measure>
    <time_frame>30 days</time_frame>
    <description>DNA sequencing of bacteria in oral buccal mucosal cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Melphalan exposure</measure>
    <time_frame>30 days</time_frame>
    <description>Concentration of Melphalan in plasma samples</description>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Mucositis</condition>
  <condition>Multiple Myeloma</condition>
  <condition>Amyloidosis</condition>
  <condition>Oral Mucositis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Melphalan kinetic study</intervention_name>
    <description>Concentration of Melphalan in plasma samples</description>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Oral bacterial study</intervention_name>
    <description>DNA from oral buccal mucosal cells will be sequenced for bacterial composition</description>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Gene expression study</intervention_name>
    <description>RNA from oral buccal mucosal cells will be analyzed to compare gene expression</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cells collected from oral mucosal samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with Melphalan who undergo autologous stem cell transplant at the Indiana&#xD;
        University Health Melvin and Bren Simon Cancer Center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with multiple myeloma (MM) or systemic light-chain amyloidosis who are&#xD;
             receiving high-dose Melphalan (HDM) and autologous peripheral blood stem cell&#xD;
             transplantation (ASCT).&#xD;
&#xD;
          2. Age is greater than 18 years old&#xD;
&#xD;
          3. Patients receiving a total Melphalan dose of 140-200 mg/m2 as the preparative regimen&#xD;
&#xD;
          4. No prior history of allogeneic stem cell transplantation&#xD;
&#xD;
          5. Patients otherwise meeting all standard institutional criteria for ASCT&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Patients who do not meet inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheriff Farag, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University School of Medicine, Indiana University Simon Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University Health Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Melvin and Bren Simon Cancer Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 26, 2015</study_first_submitted>
  <study_first_submitted_qc>October 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2015</study_first_posted>
  <last_update_submitted>November 11, 2020</last_update_submitted>
  <last_update_submitted_qc>November 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University School of Medicine</investigator_affiliation>
    <investigator_full_name>Sherif S. Farag</investigator_full_name>
    <investigator_title>Professor of Medicine and Medical and Molecular Genetics</investigator_title>
  </responsible_party>
  <keyword>Stem Cell Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Mucositis</mesh_term>
    <mesh_term>Stomatitis</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melphalan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

